Bandhan Nifty Smallcap 250 Index Fund - Direct Plan

Our Funds / ETF/Index Funds

Bandhan Nifty Smallcap 250 Index Fund - Direct Plan

The fund aims to replicate the Nifty Smallcap 250 Index by investing in the underlying securities in the same proportion, subject to tracking error. 

Nifty Smallcap 250 represents the balance 250 companies (companies ranked 251-500) from Nifty 500.

ETF/IndexInception Date:22/12/2023
Ask an Advisor

The investment objective of the Scheme is to replicate the Nifty Smallcap 250 Index by investing in securities of the Nifty Smallcap 250 Index in the same proportion / weightage with an aim to provide returns before expenses that tracks the total return of Nifty Smallcap 250 Index, subject to tracking errors. However, there is no assurance or guarantee that the objectives of the scheme will be realized and the scheme does not assure or guarantee any returns.

  • Min Investment 1,000
  • Min SIP Amount 100
  • Exit Load

    Nil

Select

This scheme has not completed one year.

NAV 10.9171 as on 01/03/20241 Day Change: 0.07(0.63%)

Tier 1 Benchmark : Nifty Smallcap 250 IndexAlternate Benchmark :

This is a new scheme and required performance data is not yet available.

This fund is managed by Mr. Nemish Sheth (w.e.f 22/12/2023)

View fund performance of other funds managed by Mr. Nemish Sheth

Past performance may or may not be sustained in future.
Regular and Direct Plans have different expense structure. Direct Plan shall have a lower expense ratio excluding distribution expenses, commission expenses etc.

Taxation:

For taxation, please refer the link :  https://bit.ly/3spfzbo

Bandhan Nifty Smallcap 250 Index Fund

(Scheme Risk-o-meter)

Investors understand that their principal will be at Very High Risk.

Nifty Smallcap 250 Index

(Tier 1 Benchmark Risk-o-meter)

This product is suitable for investors who are seeking*:
• To create wealth over long term
• Investment in equity and equity related instruments belonging to Nifty Smallcap 250 Index

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.